Amplimmune, Inc
AstraZeneca is a global, science-led, patient-focused pharmaceutical company dedicated to accelerating the delivery of life-changing medicines. They focus on transforming healthcare through innovative science, collaboration, and sustainable practices, aiming to improve patient outcomes and create value for society and shareholders.
Industries
Nr. of Employees
Very Large (1000+)
Amplimmune, Inc
Rockville, Maryland, United States, North America
Products
Investigational therapy pipeline (portfolio of clinical and preclinical projects)
A diversified portfolio of investigational therapies spanning oncology, biopharmaceuticals, vaccines, immune therapies and rare diseases with programmes across discovery to late-stage clinical development.
Open Innovation platform (compound libraries and technologies)
An external-facing platform providing access to optimized compounds, libraries, technologies and data to support preclinical research and target validation.
Investigational therapy pipeline (portfolio of clinical and preclinical projects)
A diversified portfolio of investigational therapies spanning oncology, biopharmaceuticals, vaccines, immune therapies and rare diseases with programmes across discovery to late-stage clinical development.
Open Innovation platform (compound libraries and technologies)
An external-facing platform providing access to optimized compounds, libraries, technologies and data to support preclinical research and target validation.
Services
End-to-end partnership services including deal assessment, alliance governance, integration planning and ongoing collaboration management.
Access to optimized compound collections, technologies and data for preclinical and non-clinical research through an open-innovation platform.
Support for externally sponsored research including provision of compounds for non-clinical and clinical research across specified therapeutic areas.
Provision and internal deployment of AI/ML platforms for molecular property prediction, disease-prediction tools and analytics to accelerate discovery.
Supplier finance support, e-invoicing portals and procurement enablement including Coupa and supply chain financing options.
Guidance and hub resources to help suppliers meet sustainability standards and decarbonisation requirements for procurement.
End-to-end partnership services including deal assessment, alliance governance, integration planning and ongoing collaboration management.
Access to optimized compound collections, technologies and data for preclinical and non-clinical research through an open-innovation platform.
Support for externally sponsored research including provision of compounds for non-clinical and clinical research across specified therapeutic areas.
Provision and internal deployment of AI/ML platforms for molecular property prediction, disease-prediction tools and analytics to accelerate discovery.
Supplier finance support, e-invoicing portals and procurement enablement including Coupa and supply chain financing options.
Guidance and hub resources to help suppliers meet sustainability standards and decarbonisation requirements for procurement.
Expertise Areas
- Drug discovery and development
- Clinical trial management and clinical innovation
- Precision medicine and companion diagnostics
- Cell and gene therapy development
Key Technologies
- Machine learning / AI for drug discovery
- Next-generation sequencing
- CRISPR and genome-editing technologies
- Lipid nanoparticle delivery